PILL — Canntab Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Canntab Therapeutics, fiscal year end - May 31st, CAD millions except per share, conversion factor applied.
R2018 May 31st | 2019 May 31st | 2020 May 31st | 2021 May 31st | 2022 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.41 | -2.46 | -2.61 | -4.42 | -3.69 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.954 | 0.362 | 0.281 | 1.67 | 0.391 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.135 | -0.317 | 0.131 | -0.647 | -0.182 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -1.27 | -2.33 | -1.9 | -2.85 | -2.85 |
| Capital Expenditures | -0.199 | -0.318 | -0.905 | -0.345 | -0.088 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -2.7 | 2.33 | 1.18 | 0 | 0.239 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -2.9 | 2.01 | 0.27 | -0.345 | 0.151 |
| Financing Cash Flow Items | -0.481 | 0 | -0.272 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.73 | 0.022 | 3.31 | 2.59 | 1.89 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.559 | -0.304 | 1.68 | -0.6 | -0.8 |